anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

208,321-208,380 of 319,975

filter-aware
14
The slide uses a three-column layout to present key performance indicators related to workforce diversity, product sustainability, and environmental impact.Honest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · KPI OverviewLoop · Pareto Focus1 hit
15
Honest | Investor Conference Presentation Deck | 19 slidesHonest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · Financial OverviewLoop · Cost Of Inaction1 hit
16
Honest | Investor Conference Presentation Deck | 19 slidesHonest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · Financial OverviewLoop · Cost Of Inaction1 hit
17
The slide uses a house-shaped diagram to represent the pillars of the transformation strategy.Honest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · Propose SolutionLoop · Quick Win Big Bet1 hit
18
Honest | Investor Conference Presentation Deck | 19 slidesHonest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · Key Takeaways1 hit
19
Honest | Investor Conference Presentation Deck | 19 slidesHonest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations 1 hit
01
Slide 1
HSBC | Investor Event Presentation Deck | 10 slidesHSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations Beat · What Is1 hit
02
The slide uses a pyramid-like structure to represent strategic pillars.HSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations Beat · What Is1 hit
03
The slide uses a before-after style layout to map strategic goals to specific quantitative outcomes.HSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations Beat · What Could Be1 hit
04
The slide uses a map-based layout to connect specific business initiatives to geographic regions.HSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations Beat · What Could BeLoop · Voice Of Customer1 hit
05
Slide 4 of a presentation, likely HSBC given the branding.HSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations Beat · What Could BeLoop · Voice Of Customer1 hit
06
HSBC | Investor Event Presentation Deck | 10 slidesHSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations Beat · New Bliss1 hit
07
The slide explains the transition to IFRS 17 and how 'adjusted performance' metrics are calculated.HSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations 1 hit
08
HSBC | Investor Event Presentation Deck | 10 slidesHSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations 1 hit
09
HSBC | Investor Event Presentation Deck | 10 slidesHSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations 1 hit
10
This is a standard corporate branding slide, likely used as a title or transition page.HSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations 1 hit
01
Slide 1
Kering | Mergers and Acquisitions Presentation Deck | 15 slidesKering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
02
Kering | Mergers and Acquisitions Presentation Deck | 15 slidesKering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
03
The image emphasizes luxury, craftsmanship, and brand heritage through the use of white gloves and detailed bottle design.Kering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
04
Kering | Mergers and Acquisitions Presentation Deck | 15 slidesKering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
05
Kering | Mergers and Acquisitions Presentation Deck | 15 slidesKering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
06
Uses a pyramid framework to segment the fragrance market by value tier.Kering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank Beat · Problem1 hit
07
The slide uses a bulleted list to narrate the brand's historical timeline and value proposition.Kering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
08
The slide uses a donut chart visual to represent the sales mix of the portfolio.Kering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
09
The slide uses a three-column layout to present key operational metrics alongside brand imagery.Kering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
10
Kering | Mergers and Acquisitions Presentation Deck | 15 slidesKering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
11
Kering | Mergers and Acquisitions Presentation Deck | 15 slidesKering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
12
Kering | Mergers and Acquisitions Presentation Deck | 15 slidesKering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
13
Kering | Mergers and Acquisitions Presentation Deck | 15 slidesKering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
14
Kering | Mergers and Acquisitions Presentation Deck | 15 slidesKering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
15
Handwritten-style font used for the tagline.Kering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
01
Slide 1
Includes company logo and date.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
02
Kymera | Investor Presentation Deck | 60 slidesKymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
03
The slide uses a split-layout with a company profile on the left and a list of key accomplishments on the right.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
04
TPD = Targeted Protein Degradation. UD = Undrugged. ID = Inadequately Drugged. PK = Pharmacokinetics. PD = Pharmacodynamics. SMI = Small Molecule Inhibitor.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
05
TPD = Targeted Protein Degradation; PK = Pharmacokinetics; PD = Pharmacodynamics; HS = Hidradenitis Suppurativa; AD = Atopic Dermatitis.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
06
The slide uses a dot-matrix representation to indicate therapeutic focus areas for specific drug candidates.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
07
The slide uses a Gantt-style chart to show the progression of various drug programs (IRAK4, IRAKIMiD, STAT3, MDM2, etc.) through discovery, IND enabling, and clinical phases.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
08
Kymera | Investor Presentation Deck | 60 slidesKymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
09
This is a stylistic section divider slide with an abstract background.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
10
The slide uses a biological pathway diagram to illustrate the mechanism of action and a callout box for the therapeutic thesis.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
11
The slide uses a combination of a biological mechanism diagram, a market data table, and a comparative analysis of current therapy limitations.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
12
The slide uses a split-screen comparison between healthy volunteer data and patient data.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
13
The slide uses a bulleted list structure to categorize findings between healthy volunteers and patients, concluding with a strategic partnership milestone.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
14
Clinical trial baseline data table.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
15
The slide provides a breakdown of patient outcomes including completion and withdrawal reasons.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
16
HS = Hidradenitis Suppurativa; AD = Atopic Dermatitis; HV = Healthy Volunteers; MAD = Multiple Ascending Dose; LLOQ = Lower Limit of Quantitation.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
17
The chart shows a clear reduction in IRAK4 protein levels in both AD and HS patient groups after 28 days of treatment, bringing them down to or below the baseline levels of healthy subjects.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
18
The slide compares cytokine inhibition efficacy in Healthy Subjects (MAD3), AD patients, and HS patients using two different stimulation methods (LPS and R848).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
19
The chart specifically visualizes IL-6 reduction over time, while the table summarizes max reduction across four markers.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
20
The slide uses individual patient data points (AD-1 to AD-7, HS-1 to HS-12) to show consistent downregulation across cohorts.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
21
Data presented as mean percentage change with standard error bars; N=7.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
22
The chart tracks patient outcomes over time, showing a shift from severe/moderate to mild categories.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
23
Includes clinical photography, efficacy endpoint table, and biomarker data (cytokines and RNAseq).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
24
The slide uses a comparison table to highlight efficacy metrics (EASI, Pruritus NRS) across different time points and benchmarks.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
25
Data compares 'All HS Patients' vs 'Moderate to Severe' subgroups. Includes error bars representing standard error of the mean or 80% confidence intervals.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
26
Data presented across three line charts comparing 'All HS Patients' vs 'Moderate to Severe' subgroups.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
27
The charts demonstrate a shift from higher severity scores (orange/red) to lower severity scores (blue/black) over time.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
28
Includes clinical efficacy table and RNAseq biomarker reduction chart.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
29
Includes patient profile, clinical efficacy table, before/after photos, and cytokine biomarker tracking.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit